Organization Overview
Historical Acquisition Tree
Alternative names
Key: SmithKline Beecham (33) Acquired (10)
acetaminophen (tylenol) (1997)
acetylsalicylic acid (aspirin) (1990)
albendazole (Albenza) (NDA)
brimonidine (alphagan) (1996)
butalbital (fiornal) (1990)
caffeine (1990)
carvedilol (coreg) (1995 NDA)
codeine (Phenergan) (1990)
diltiazem (cardizem) (1992)
eprosartan (teveten) (NDA)
estradiol (progynon depot) (1996)
ethinyl estradiol (Estinyl) (1996)
fluorometholone (fml) (1989)
gentamicin (garamycin) (1989)
glimepiride (amaryl) (2005)
hepatitis-a virus (inactivated) / hepatitis-b surface antigen (twinrix) (2001 NDA)
hydrocodone (hycodan) (1997)
icosapent ethyl (vascepa) (2004)
isradipine (dynacirc) (1990)
ketorolac (acuvail) (1997)
lamotrigine (lamictal) (2010)
lapatinib (tykerb) (2000)
levobunolol (betagan) (1989)
mesalamine (rowasa) (1992)
metformin (glucophage) (2002)
morphine (1996)
nabumetone (relafen) (1991 NDA)
nedocromil (tilade) (1999)
nizatidine (axid) (1988 NDA)
norethindrone (1996)
ofloxacin (floxin) (1993)
omega-3 fatty acids (Omacor) (2004)
onabotulinumtoxinA (Botox) (1991 NDA)
podofilox (condylox) (1997)
prednisone (meticorten) (1989)
progesterone (progestasert) (1997)
risedronate (actonel) (1998)
ropinirole (Requip) (NDA)
rosiglitazone (1999)
sitagliptin (januvia) (1999)
sulfacetamide (sultrin) (1989)
tazarotene (tazorac) (1997)
ursodeoxycholic acid (1997)
Key: SmithKline Beecham (7) Acquired (65)
adapalene (differin) (4 trials)
aflibercept (zaltrap) (3 trials)
alcaftadine (Lastacaft) (6 trials)
benzoyl peroxide (clearasil) (2 trials)
bevacizumab (avastin) (8 trials)
bimatoprost (lumigan) (71 trials)
brimonidine (alphagan) (35 trials)
brinzolamide (azopt) (2 trials)
carboxymethyl cellulose (3 trials)
cefotaxime (claforan) (1 trial)
ceftaroline fosamil (teflaro) (1 trial)
ceftriaxone (rocephin) (2 trials)
cyclosporine (sandimmune) (17 trials)
dalbavancin (dalvance) (14 trials)
deoxycholic acid (kybella) (5 trials)
dorzolamide (trusopt) (4 trials)
duloxetine (Cymbalta) (1 trial)
eluxadoline (viberzi) (5 trials)
gatifloxacin (Zymar) (7 trials)
hepatitis b vaccine (recombinant) (Recombivax) (1 trial)
ketorolac (acuvail) (9 trials)
latanoprost (xalatan) (12 trials)
linaclotide (linzess) (10 trials)
metronidazole (flagyl) (2 trials)
minocycline (minocin) (1 trial)
moxifloxacin (avelox) (4 trials)
naphazoline (visine) (1 trial)
nepafenac (nevanac) (4 trials)
netilmicin (netromycin) (1 trial)
olopatadine (patanol) (4 trials)
omega-3 fatty acids (Omacor) (1 trial)
onabotulinumtoxinA (Botox) (37 trials)
oxybutynin (ditropan) (2 trials)
oxymetazoline (ocuclear) (4 trials)
pheniramine (Tripoton) (1 trial)
prednisone (meticorten) (3 trials)
ranibizumab (lucentis) (18 trials)
rimabotulinumtoxinB (Myobloc) (129 trials)
sitagliptin (januvia) (3 trials)
tafluprost (zioptan) (1 trial)
tazarotene (tazorac) (5 trials)
testosterone (delatestryl) (2 trials)
timolol (blocadren) (35 trials)
tizanidine (zanaflex) (1 trial)
topiramate (topamax) (2 trials)
travoprost (travatan) (6 trials)
triamcinolone (kenalog) (7 trials)
Key: SmithKline Beecham (4) Acquired (34)
budesonide (rhinocort) (6 trials)
cariprazine (vraylar) (12 trials)
dihydroergotamine (D.H.E. 45) (5 trials)
escitalopram (lexapro) (1 trial)
fluoxetine (prozac) (3 trials)
Key: SmithKline Beecham (11) Acquired (30)
autologous hematopoietic stem cells (1 trial)
beclomethasone (vanceril) (1 trial)
carboplatin (paraplatin) (1 trial)
ceftazidime (fortaz) (3 trials)
ciprofloxacin (cipro) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
daunorubicin (cerubidine) (1 trial)
Key: SmithKline Beecham (1) Acquired (15)
Key: SmithKline Beecham (0) Acquired (4)
Carcinoma, Ovarian Epithelial (Phase 2)
Communicable Diseases (Phase 3)
Depression (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Hepatitis (Phase 4)
Hepatitis B (Phase 4)
Hypertension (Phase 4)
Infections (Phase 3)
Insulin Resistance (Phase 4)
Leukemia (Phase 2)
Leukoencephalopathies (Phase 2)
Lung Neoplasms (Phase 3)
Malaria (Phase 2)
Microsporidiosis (Phase 3)
Multiple Myeloma (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Ovarian Neoplasms (Phase 2)
Parasitemia (Phase 2)
Plasmacytoma (Phase 1)
Pneumonia (Phase 4)
Pneumonia, Ventilator-Associated (Phase 4)
Protozoan Infections (Phase 3)
Small Cell Lung Carcinoma (Phase 3)